Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors.

Yuyu He; Jie Li; Tomoyuki Koga; Jun Ma; Sanjay Dhawan; Yuta Suzuki; Frank Furnari; Varun Vijay  Prabhu; Joshua Allen; Clark C Chen

Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors.

Yuyu He, Jie Li, Tomoyuki Koga, Jun Ma, Sanjay Dhawan, Yuta Suzuki, Frank Furnari, Varun Vijay Prabhu, Joshua Allen, Clark C Chen

Neurosurgery

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	Neuro-Oncology
State	Published - Aug 2020

OpenUrl availability

Full text

Cite this

@article{b427bf38c1c848a1bfbef24e2a01313e,

title = "Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors.",

author = "Yuyu He and Jie Li and Tomoyuki Koga and Jun Ma and Sanjay Dhawan and Yuta Suzuki and Frank Furnari and Prabhu, {Varun Vijay} and Joshua Allen and Chen, {Clark C}",

year = "2020",

month = aug,

language = "English (US)",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Epidermal Growth Factor Receptor (EGFR) as a molecular determinant of glioblastoma response to dopamine receptor 2 (DRD2) inhibitors.

AU - He, Yuyu

AU - Li, Jie

AU - Koga, Tomoyuki

AU - Ma, Jun

AU - Dhawan, Sanjay

AU - Suzuki, Yuta

AU - Furnari, Frank

AU - Prabhu, Varun Vijay

AU - Allen, Joshua

AU - Chen, Clark C

PY - 2020/8

Y1 - 2020/8

M3 - Article

SN - 1522-8517

JO - Neuro-Oncology

JF - Neuro-Oncology

ER -